Last reviewed · How we verify
NCT03945396
Homeopathy for Overweight and Obesity in Mexican Adolescents
Phase 2 trial testing Homeopathic Medication in Overweight and Obesity in 60 participants. Status unknown.
30 November 2022
Quick facts
| Lead sponsor | Hospital Juarez de Mexico |
|---|---|
| Phase | Phase 2 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 6 May 2019 |
| Primary completion | 30 November 2022 |
| Estimated completion | 30 December 2022 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Homeopathic Medication — full drug profile →
- Multidisciplinary intervention (Exercise program, diet, motivational support)
- Homeopathic placebo — full drug profile →
Conditions studied
- Overweight and Obesity — all drugs for Overweight and Obesity →
Sponsor
Hospital Juarez de Mexico
Who can join
Adults 12 to 19, any sex, with Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the efficacy of a multidisciplinary intervention (diet, exercise, motivational support and homeopathy or placebo) for overweight and obesity in Mexican adolescents. Half of study participants will receive the multidisciplinary intervention plus Calcarea carbonica ostrearum, a homeopathic medicine, while the other half will receive the same multidisciplinary intervention plus placebo.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of Homeopathy in Addition to a Multidisciplinary Intervention for Overweight or Obesity in Mexican Adolescents: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial.
Macías-Cortés E, Arellano-Álvarez S, Vega-Monroy S, Vera-Pérez V, et al · · 2020 · PMID 31958867 · DOI 10.1055/s-0039-1697927
Verify or expand the search:
- PubMed search for NCT03945396
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Homeopathic Medication
Trials testing the same drug.
- NCT05104749 — Homeopathic Treatment of Post-acute COVID-19 Syndrome · Phase 3 · completed
- NCT03512639 — Arnica Montana and Bellis Perennis for Prevention of Seroma After Mastectomy · NA · completed
Other recruiting trials for Overweight and Obesity
Currently open trials in the same condition.
- NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
- NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
- NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
Other Hospital Juarez de Mexico trials
Trials by the same sponsor.
- NCT05378282 — Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics · completed
- NCT04164394 — Effect of I31 Probiotic on Lactose Intolerance · NA · completed
- NCT04145856 — Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico · Phase 4 · completed
- NCT03849729 — Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery · Phase 4 · completed
- NCT04470791 — Cryotherapy as a Coadjuvant in Crotaline Snakebite Management With Antivenom. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03945396 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Juarez de Mexico
- Last refreshed: 25 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03945396.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing